Navigation Links
Osseon Signs International Distribution Agreement With MBA Incorporado
Date:9/22/2009

SANTA ROSA, Calif., Sept. 22 /PRNewswire/ -- Osseon Therapeutics, Inc., a Santa Rosa, California, manufacturer of spinal medical devices for the minimally invasive treatment of spinal compression fractures, today announced it has signed a five-year agreement with MBA Incorporado, SL to distribute Osseon's suite of products in the European and South American markets. MBA is a leading medical device marketing and distribution organization and specializes in the sale of products used for treatment of the spine. MBA is the largest private independent distributor of orthopaedic devices in Europe, generating more than $100 million in total sales in 2008.

Osseon's product line features the Osseoflex and Osseoperm. These products combine to form a unique new procedure termed Osseoplasty to treat painful acute fractures of the vertebrae seen increasingly in older individuals with osteoporosis and osteo-traumatic injuries.

Osseoflex is a steerable and curvable needle that can access the majority of the vertebral body from a single percutaneous access point. The Osseoperm system is customized for delivering optimal viscosity cement and precise cement placement through the Osseoflex needle. The Osseoplasty procedure provides rapid stabilization of vertebral fractures and significant pain relief in most patients within the same day.

MBA will distribute Osseon's devices to physicians and hospitals throughout the European Union, including the United Kingdom, Germany, Spain, Portugal, Italy, Greece, Austria, Switzerland, Scandinavia, France, Benelux, Turkey and Germany, as well as Latin America.

"Osseon is excited to partner with MBA, the leading distributor of biomedical spine treatment products in Europe and South America," said Dr. John Stalcup, CEO of Osseon Therapeutics. "MBA is known as the 'state-of-the-science' innovator in these markets for medical devices, always at the forefront of distribution and support of advanced medical technologies. Having MBA as our exclusive distributor will bring immediate and long-lasting relationships with the leading physicians and hospitals treating spinal compression fractures. We are, indeed, pleased to have MBA as our sole representative."

Paul Griffin, MBA's Chief Operating Officer and a member of their Board of Directors said, "MBA is honored that Osseon has chosen our Organization as its marketing and distribution partner for this unique technology for Europe and South America. We are delighted with this Agreement, which represents a huge opportunity for both our Organizations to facilitate the introduction of this exciting and new therapeutic option to specialists in many countries outside the U.S., who are treating an ever-increasing number of painful vertebral compression fractures in older patients." Paul Griffin added, "We feel confident that the combination of Osseon's impressive product portfolio together with MBA's experienced team and marketing know-how will allow us to develop and grow a very successful business together as innovators in this key market. Osseon has state-of-the-art technology and MBA has the resources to bring these remarkable devices quickly and successfully into all of the major and most competitive markets outside the U.S."

"MBA has an excellent and long-established international reputation for marketing and distributing medical devices for independent innovators and an unparalleled reputation for customer service. The Agreement today between MBA and Osseon represents a major step forward in the expansion of these services into the key markets of Europe and Latin America."

Osseon Therapeutics, Inc. was incubated at the University of Northern California's Science and Technology Innovation Center in Santa Rosa. Its first-generation products have received both FDA clearance and CE Mark for product distribution in the United States and European Union.

To learn more about Osseon, please visit our website:http://www.osseon.com/


'/>"/>
SOURCE Osseon Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Osseon Receives CE Mark
2. New device finds early signs of eye disease in preemies
3. GENova Biotherapeutics signs LOI with Korean university for stem cell research and patents sharing
4. GENova Biotherapeutics signs engagement agreement with PacificWave Partners Limited
5. Haemonetics Signs Comprehensive Agreement with Blood Centers of America
6. GENova Biotherapeutics signs collaboration agreement with Prime BioResearch
7. GENova Biotherapeutics and Prime BioResearch signs LOI on diabetes and cancer cure
8. HemCon Medical Technologies, Inc. signs exclusive global agreement with Zimmer Dental Inc. to distribute oral surgery dressings
9. Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States
10. Online Sign Making from Genuinesigns.com Just Got Faster, Easier, & Greener with its New Revolutionary System
11. Patient Safety Technologies Signs Contract with Partners HealthCare, to Implement the Safety-Sponge(TM) System at Brigham & Womens Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... -- , , , WHEN: , ... , , , LOCATION: , , , Online, with free ... EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice President ... Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... is witnessing an exceptional era. Several new demand spaces, such as ...
Breaking Medicine Technology: